Haemonetics Corporation (HAE)
Debt-to-capital ratio
| Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Long-term debt | US$ in thousands | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Total stockholders’ equity | US$ in thousands | 951,605 | 906,860 | 878,851 | 905,368 | 959,959 | 943,319 | 893,660 | 864,616 | 817,997 | 775,979 | 729,009 | 770,423 | 749,424 | 730,775 | 698,549 | 677,080 | 731,670 | 719,152 | 667,923 | 608,569 |
| Debt-to-capital ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
March 31, 2025 calculation
Debt-to-capital ratio = Long-term debt ÷ (Long-term debt + Total stockholders’ equity)
= $—K ÷ ($—K + $951,605K)
= 0.00
The debt-to-capital ratio for Haemonetics Corporation has consistently been 0.00 since June 30, 2020, through March 31, 2025. This indicates that the company has not utilized any debt to finance its operations relative to its total capital, which includes both debt and equity. A debt-to-capital ratio of 0.00 suggests that the company is relying solely on equity to fund its activities, which may signal a conservative approach to managing its capital structure and financial risk. This could indicate that Haemonetics has a strong financial position and may be less vulnerable to financial distress or fluctuations in interest rates.
Peer comparison
Mar 31, 2025